Close

Chimerix (CMRX) Names RaNA Therapeutics CEO Renaud as Director

December 18, 2014 6:24 AM EST Send to a Friend
Chimerix (NASDAQ: CMRX) announced Ronald C. Renaud, Jr. has been appointed to Chimerix's Board of Directors. Mr. Renaud currently serves ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login